Literature DB >> 7264565

Lymphokine-mediated bone resorption requires endogenous prostaglandin synthesis.

R S Bockman, M A Repo.   

Abstract

Enhanced synthesis of prostaglandin (PG) E by explanted fetal rat bones was initiated by lymphocyte-conditioned media but not by physiological levels of parathyroid hormone. Rapid release of PGE from bone occurred only when the lymphokine was present. Synthesis of PGE preceded and was necessary for the bone resorption caused by the lymphokine preparation. Local production of prostaglandins in response to inflammatory cell or tumor-derived factors may in part be responsible for the localized bone loss that occurs in certain pathological states.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7264565      PMCID: PMC2186425          DOI: 10.1084/jem.154.2.529

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  20 in total

1.  Effects of osteoclast activating factor from human lymphocytes on cyclic AMP concentrations in isolated mouse bone and bone cells.

Authors:  R A Luben; M C Chen; D M Rosen; M A Mohler
Journal:  Calcif Tissue Int       Date:  1979-08-24       Impact factor: 4.333

2.  Collagenase and bone resorption: isolation of collagenase from culture medium containing serum after stimulation of bone resorption by addition of parathyroid hormone extract.

Authors:  S Sakamoto; M Sakamoto; P Goldhaber; M Glimcher
Journal:  Biochem Biophys Res Commun       Date:  1975-03-03       Impact factor: 3.575

3.  Prostaglandin regulation of macrophage collagenase production.

Authors:  L M Wahl; C E Olsen; A L Sandberg; S E Mergenhagen
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

4.  Big and little forms of osteoclast activating factor.

Authors:  G R Mundy; L G Raisz; J L Shapiro; J G Bandelin; R J Turcotte
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

5.  Macrophage-lymphocyte synergy in the production of osteoclast activating factor.

Authors:  J E Horton; J J Oppenheim; S E Mergenhagen; L G Raisz
Journal:  J Immunol       Date:  1974-10       Impact factor: 5.422

6.  Evidence for the secretion of an osteoclast stimulating factor in myeloma.

Authors:  G R Mundy; L G Raisz; R A Cooper; G P Schechter; S E Salmon
Journal:  N Engl J Med       Date:  1974-11-14       Impact factor: 91.245

7.  Bone-resorbing activity in supernatants from lymphoid cell lines.

Authors:  G R Mundy; R A Luben; L G Raisz; J J Oppenheim; D N Buell
Journal:  N Engl J Med       Date:  1974-04-18       Impact factor: 91.245

8.  Production of osteoclast-activating factor by normal human peripheral blood rosetting and nonrosetting lymphocytes.

Authors:  P Chen; C Trummel; J Horton; J J Baker; J J Oppenheim
Journal:  Eur J Immunol       Date:  1976-10       Impact factor: 5.532

9.  Partial purification of osteoclast-activating factor from phytohemagglutinin-stimulated human leukocytes.

Authors:  R A Luben; G R Mundy; C L Trummel; L G Raisz
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

10.  Monocytes regulate osteoclast-activating factor production by releasing prostaglandins.

Authors:  T Yoneda; G R Mundy
Journal:  J Exp Med       Date:  1979-08-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Cytokine-mediated proteolysis in tissue remodelling.

Authors:  S Masure; G Opdenakker
Journal:  Experientia       Date:  1989-06-15

2.  Eosinophilic granuloma of the orbit: a paradox of aggressive destruction responsive to minimal intervention.

Authors:  Gerald J Harris; Kyung In Woo
Journal:  Trans Am Ophthalmol Soc       Date:  2003

3.  Gallium nitrate inhibits calcium resorption from bone and is effective treatment for cancer-related hypercalcemia.

Authors:  R P Warrell; R S Bockman; C J Coonley; M Isaacs; H Staszewski
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

4.  Histiocytosis X. Purified (T6+) cells from bone granuloma produce interleukin 1 and prostaglandin E2 in culture.

Authors:  F Arenzana-Seisdedos; S Barbey; J L Virelizier; M Kornprobst; C Nezelof
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

5.  Pig interleukin 1 (catabolin) is a potent stimulator of bone resorption in vitro.

Authors:  J K Heath; J Saklatvala; M C Meikle; S J Atkinson; J J Reynolds
Journal:  Calcif Tissue Int       Date:  1985-01       Impact factor: 4.333

6.  Bone resorbing activity in synovial fluids in destructive osteoarthritis and rheumatoid arthritis.

Authors:  W H Alwan; P A Dieppe; C J Elson; J W Bradfield
Journal:  Ann Rheum Dis       Date:  1988-03       Impact factor: 19.103

7.  Benign orbital tumors with bone destruction in children.

Authors:  Jianhua Yan; Sheng Zhou; Yongping Li
Journal:  PLoS One       Date:  2012-02-24       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.